Evidence map›Paper›PMID 36339813›Full record

ArticleJournal of the American Statistical Association2021

Integrating multidimensional data for clustering analysis with applications to cancer patient data.

Seyoung Park, Hao Xu, Hongyu Zhao

Abstract read
In one paragraph

Article in Journal of the American Statistical Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Nextcast: A software suite to analyse and model toxicogenomics data.Computational and structural biotechnology journal · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Seyoung ParkDepartment of Statistics, Sungkyunkwan University, Seoul, Korea.
Hao XuDepartment of Biostatistics, Yale School of Public Health, New Haven, CT.
Hongyu ZhaoDepartment of Biostatistics, Yale School of Public Health, New Haven, CT.

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Kurt A Schalper · 2015 to 2026
$31.1M
NCI NIH HHS P30 CA016359NCI NIH HHS P50 CA196530
6 · The paper itself

Abstract

Advances in high-throughput genomic technologies coupled with large-scale studies including The Cancer Genome Atlas (TCGA) project have generated rich resources of diverse types of omics data to better understand cancer etiology and treatment responses. Clustering patients into subtypes with similar disease etiologies and/or treatment responses using multiple omics data types has the potential to improve the precision of clustering than using a single data type. However, in practice, patient clustering is still mostly based on a single type of omics data or ad hoc integration of clustering results from individual data types, leading to potential loss of information. By treating each omics data type as a different informative representation from patients, we propose a novel multi-view spectral clustering framework to integrate different omics data types measured from the same subject. We learn the weight of each data type as well as a similarity measure between patients via a non-convex optimization framework. We solve the proposed non-convex problem iteratively using the ADMM algorithm and show the convergence of the algorithm. The accuracy and robustness of the proposed clustering method is studied both in theory and through various synthetic data. When our method is applied to the TCGA data, the patient clusters inferred by our method show more significant differences in survival times between clusters than those inferred from existing clustering methods.

Indexed as

Gaussian kernelMulti-omics dataSpectral clustering

Identifiers

PMID36339813
PMCPMC9634961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.